Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

ABVE vs HLF: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

HLF Wins Head-to-Head Institutional Verdict (6–0 across 6 Pillars · 8–1 Matrix Metrics)

HLF Overall Winner 6-Pillar Tally: ABVE 0 – 6 HLF Matrix Metrics: ABVE 1 – 8 HLF

As of Nov 16, 2026, Herbalife Ltd. (HLF) is the stronger overall head-to-head candidate over Above Food Ingredients Inc. (ABVE) in the Tradestie Institutional Equity Comparison Engine, winning 8–1 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). ABVE carries a Unified Composite Score of 39.8/100 (SELL) at $0.11 (N/M Forward P/E, -23.2% operating margin), whereas HLF carries 35.2/100 (SELL) at $15.93 (5.3x Forward P/E, 9.8% operating margin).

  • Composite vs. Pillar Nuance: While ABVE currently prints a higher short-term Unified Composite Score (39.8/100 SELL vs. HLF 35.2/100 SELL), HLF captures the overall institutional head-to-head verdict (8–1 matrix metrics and 6–0 across the 6 pillars) due to superior fundamental profitability (9.8% vs. -23.2% operating margin) and revenue trajectory (+6.0% vs. -45.0% YoY).
  • Defensive Composite Rating Caution: Although HLF compares more favorably head-to-head, both ABVE (39.8/100 SELL) and HLF (35.2/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
  • Technical & Structure Timing Caution: ABVE is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 28.0); meanwhile HLF trades in a Markup technical trend (SURGE options phase, RSI 68.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About ABVE vs HLF
ABVE NASDAQ
Above Food Ingredients Inc. Common Stock
Food And Kindred Products
$0.11
-80.57% 1D
Market Cap $30.0M
TTM Revenue $295M
Forward P/E N/M
Beta / 30D Vol 4.10β · 310% Vol
Unified Composite Score
39.8 / 100 SELL
Tech 40.0 Fund 47.0 Flow 57.0 Mom 40.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -29.1%), weak momentum, RSI 28
RSI-14: 28.0 · SMA20: $0.55 · SMA50: $0.67
HLF NYSE Head-to-Head Winner
Herbalife Ltd.
Wholesale-Drugs, Proprietaries & Druggists' Sundries
$15.93
-0.19% 1D
Market Cap $1.6B
TTM Revenue $5.28B
Forward P/E 5.3x
Beta / 30D Vol 1.08β · 48% Vol
Unified Composite Score
35.2 / 100 SELL
Tech 50.0 Fund 31.0 Flow 59.0 Mom 40.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (7.2% over 20 days), RSI 69
RSI-14: 68.8 · SMA20: $14.39 · SMA50: $13.36

6-Pillar Scorecard Institutional Category Breakdown (ABVE 0 – 6 HLF)

Columns: Metric · ABVE · HLF
1. Valuation Multiples HLF
Forward P/E N/M 5.3x
Trailing P/E N/M 8.9x
PEG Ratio N/M 0.61x
EV / Revenue 0.1x 0.6x
2. Growth & Scale HLF
Revenue Growth (YoY) -45.0% +6.0%
Earnings Growth (YoY) +0.0% +31.5%
TTM Revenue (USD) $295M $5.28B
Market Cap $30.0M $1.6B
3. Profitability & Quality HLF
Gross Margin -2.8% 77.6%
Operating Margin -23.2% 9.8%
Net Profit Margin -23.4% 3.4%
Return on Equity (ROE) 0.0% 0.0%
4. Balance Sheet & Cash Flow HLF
Cash Generation (TTM) -$40M EBITDA $337M
Cash Flow Margin -13.7% EBITDA Mgn 6.4%
Net Cash / Leverage 0.0% ROE $1.70B Net Debt
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning HLF
Options Structure Phase UNCLASSIFIED SURGE
Current IV / %ile 148.3% (8th %ile) 77.8% (8th %ile)
Put/Call OI Skew N/A 0.21x (Call-Skewed)
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Markup
6. R&D & Supply-Chain Moat HLF
OpEx & R&D Intensity 20.4% of Rev ($60M) 67.8% of Rev ($3.58B)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Packaged Foods Operator Packaged Foods Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: ABVE (1) vs HLF (8)
Institutional Metric ABVE HLF Criterion Row Edge
Market Capitalization
Scale
$30.0M $1.6B Larger Scale HLF
Trailing P/E Ratio
Valuation
N/M 8.9x Lower Multiple HLF
Forward P/E Ratio
Valuation
N/M 5.3x Lower Multiple HLF
Revenue Growth (YoY)
Growth
-45.0% +6.0% Higher Growth HLF
Operating Margin (TTM)
Profitability
-23.2% 9.8% Higher Margin HLF
Net Profit Margin
Profitability
-23.4% 3.4% Higher Margin HLF
Return on Equity (ROE)
Capital Efficiency
0.0% 0.0% Higher ROE Tie
52-Week Range Position
Momentum
0% ($0–$7) 62% ($9–$20) Stronger Trend HLF
Beta / 30D Volatility
Risk Regime
4.10β · 310% Vol 1.08β · 48% Vol Lower Realized Risk HLF
Unified Institutional Score
Composite Signal
39.8 / 100 (SELL) 35.2 / 100 (SELL) Higher Composite ABVE
Trailing 12M Revenue (USD)
Operating Scale
$295M $5.28B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
-2.8% 77.6% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 0.1x EV/Rev 0.61x PEG · 0.6x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$40M EBITDA (0.0% ROE) $337M ($1.70B Net Debt) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon HLF +50.87 pp
ABVE: -79.18% · HLF: -28.31%
3M Horizon HLF +53.28 pp
ABVE: -91.43% · HLF: -38.15%
6M Horizon HLF +84.88 pp
ABVE: -95.67% · HLF: -10.79%
1Y Horizon HLF +120.57 pp
ABVE: -94.38% · HLF: +26.19%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ABVE vs HLF. Trailing 12-month operating profitability (ABVE -23.2% vs HLF 9.8%) and valuation multiples (ABVE N/M vs HLF 5.3x Forward P/E) are benchmarked directly in Pillar 4 below.

ABVE ADR TTM Benchmark FX-Normalized USD
TTM Revenue$295M
Gross Margin-2.8%
Op. Margin-23.2%
ROE / Fwd P/E0.0% · N/M
HLF ADR TTM Benchmark FX-Normalized USD
TTM Revenue$5.28B
Gross Margin77.6%
Op. Margin9.8%
ROE / Fwd P/E0.0% · 5.3x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
ABVE UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 148.3%
IV Percentile 8th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact ABVE Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
HLF SURGE
5d in phase · OBV NEUTRAL
Current IV 77.8%
IV Percentile 8th %ile
Put/Call OI Skew 0.21x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact HLF Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
ABVE Moat Profile Cyclical / Execution-Driven Positioning
Packaged Foods Operator
Competes within the Packaged Foods value chain with $30.0M market capitalization and -23.2% operating margin.
OpEx & R&D Reinvestment 20.4% of Rev ($60M)
90D Engineering Disclosures 0 Published
HLF Moat Profile Cyclical / Execution-Driven Positioning
Packaged Foods Operator
Competes within the Packaged Foods value chain with $1.6B market capitalization and 9.8% operating margin.
OpEx & R&D Reinvestment 67.8% of Rev ($3.58B)
90D Engineering Disclosures 0 Published

Investor FAQ ABVE vs HLF Key Questions & Quantitative Answers

As of Nov 16, 2026, Herbalife Ltd. (HLF) is the stronger overall head-to-head candidate over Above Food Ingredients Inc. (ABVE) in the Tradestie Institutional Equity Comparison Engine, winning 8–1 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). ABVE carries a Unified Composite Score of 39.8/100 (SELL) at $0.11 (N/M Forward P/E, -23.2% operating margin), whereas HLF carries 35.2/100 (SELL) at $15.93 (5.3x Forward P/E, 9.8% operating margin). Composite vs. Pillar Nuance: While ABVE currently prints a higher short-term Unified Composite Score (39.8/100 SELL vs. HLF 35.2/100 SELL), HLF captures the overall institutional head-to-head verdict (8–1 matrix metrics and 6–0 across the 6 pillars) due to superior fundamental profitability (9.8% vs. -23.2% operating margin) and revenue trajectory (+6.0% vs. -45.0% YoY). Defensive Composite Rating Caution: Although HLF compares more favorably head-to-head, both ABVE (39.8/100 SELL) and HLF (35.2/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model. Technical & Structure Timing Caution: ABVE is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 28.0); meanwhile HLF trades in a Markup technical trend (SURGE options phase, RSI 68.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

HLF leads the Growth & Scale pillar: ABVE posts -45.0% YoY revenue growth and +0.0% YoY earnings growth on $295M TTM revenue (-2.8% gross margin, -23.2% operating margin), compared with HLF at +6.0% YoY revenue growth and +31.5% YoY earnings growth on $5.28B TTM revenue (77.6% gross margin, 9.8% operating margin). On trailing 12-month operating scale, ABVE generates $295M in USD-normalized revenue versus $5.28B for HLF. In operating R&D and SG&A reinvestment, ABVE deploys 20.4% of Rev ($60M) (0 90-day corporate R&D disclosures) versus 67.8% of Rev ($3.58B) (0 disclosures) for HLF.

HLF screens cheaper on headline valuation multiples. ABVE trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.1x EV/Revenue (-13.7% EBITDA margin), whereas HLF trades at 5.3x Forward P/E, 8.9x Trailing P/E, 0.61x PEG, and 0.6x EV/Revenue (6.4% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ABVE (0.0% ROE) versus HLF (0.0% ROE) capital efficiency.

In options market volatility and institutional positioning, ABVE carries 148.3% implied volatility (8th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (4.10β · 310% Vol realized risk). By comparison, HLF carries 77.8% implied volatility (8th %ile, Compressed (<25th %ile)), a 0.21x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a SURGE options structure phase (1.08β · 48% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.